IBDEI0XF ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16502,0)
 ;;=788.20^^92^938^63
 ;;^UTILITY(U,$J,358.3,16502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16502,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,16502,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,16502,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,16503,0)
 ;;=112.2^^92^938^66
 ;;^UTILITY(U,$J,358.3,16503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16503,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,16503,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,16503,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,16504,0)
 ;;=600.01^^92^938^5
 ;;^UTILITY(U,$J,358.3,16504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16504,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,16504,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,16504,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,16505,0)
 ;;=600.10^^92^938^40
 ;;^UTILITY(U,$J,358.3,16505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16505,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,16505,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,16505,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,16506,0)
 ;;=585.9^^92^938^8
 ;;^UTILITY(U,$J,358.3,16506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16506,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,16506,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,16506,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,16507,0)
 ;;=788.64^^92^938^59
 ;;^UTILITY(U,$J,358.3,16507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16507,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,16507,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,16507,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,16508,0)
 ;;=788.65^^92^938^52
 ;;^UTILITY(U,$J,358.3,16508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16508,1,4,0)
 ;;=4^788.65
 ;;^UTILITY(U,$J,358.3,16508,1,5,0)
 ;;=5^Straining of Urination
 ;;^UTILITY(U,$J,358.3,16508,2)
 ;;=^334166
 ;;^UTILITY(U,$J,358.3,16509,0)
 ;;=600.00^^92^938^4
 ;;^UTILITY(U,$J,358.3,16509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16509,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,16509,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,16509,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,16510,0)
 ;;=599.70^^92^938^20
 ;;^UTILITY(U,$J,358.3,16510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16510,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,16510,1,5,0)
 ;;=5^Hematuria
 ;;^UTILITY(U,$J,358.3,16510,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,16511,0)
 ;;=599.71^^92^938^21
 ;;^UTILITY(U,$J,358.3,16511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16511,1,4,0)
 ;;=4^599.71
 ;;^UTILITY(U,$J,358.3,16511,1,5,0)
 ;;=5^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,16511,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,16512,0)
 ;;=599.72^^92^938^22
 ;;^UTILITY(U,$J,358.3,16512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16512,1,4,0)
 ;;=4^599.72
 ;;^UTILITY(U,$J,358.3,16512,1,5,0)
 ;;=5^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,16512,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,16513,0)
 ;;=596.89^^92^938^12
 ;;^UTILITY(U,$J,358.3,16513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16513,1,4,0)
 ;;=4^596.89
 ;;^UTILITY(U,$J,358.3,16513,1,5,0)
 ;;=5^Cystocele
 ;;^UTILITY(U,$J,358.3,16513,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,16514,0)
 ;;=596.81^^92^938^15
 ;;^UTILITY(U,$J,358.3,16514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16514,1,4,0)
 ;;=4^596.81
 ;;^UTILITY(U,$J,358.3,16514,1,5,0)
 ;;=5^Cystostomy Infection
 ;;^UTILITY(U,$J,358.3,16514,2)
 ;;=^340556
 ;;^UTILITY(U,$J,358.3,16515,0)
 ;;=596.82^^92^938^13
 ;;^UTILITY(U,$J,358.3,16515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16515,1,4,0)
 ;;=4^596.82
 ;;^UTILITY(U,$J,358.3,16515,1,5,0)
 ;;=5^Cystostomy Complication,Mechanical
